Please provide your email address to receive an email when new articles are posted on . PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with ...

At 1 year, women experienced similar target lesion failure and ischemic outcomes compared with men after PCI with a dual-therapy stent, according to research published in Catheterization and ...

In patients with three-vessel and/or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) with paclitaxel-eluting stents is equivalent to coronary artery bypass grafting ...

(HealthDay News) — For patients with multivessel coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents is linked to increased cardiovascular events vs.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...

Rasha Al-Lamee, MD (Imperial College London, United Kingdom) calmly delivered the findings that improvements in exercise capacity and angina symptoms were not significantly different between patients ...

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ...

WASHINGTON, DC – The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported today at the 26th annual Transcatheter ...

Despite the morbidity associated with coronary artery bypass graft, this procedure has never been entirely displaced by percutaneous coronary intervention. The results from the latest in a series of ...

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a ...